Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.48 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 9/20 | 0.43 |
| ▸ | CTSD | P07339 | 3/20 | 0.42 |
| ▸ | MME | P08473 | 2/20 | 0.40 |
| ▸ | ECE1 | P42892 | 2/20 | 0.39 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30390448 | 0.95 | CD274 (0.52) | PDCD1LG2CD274BACE1CTSDMME | |
| SCHEMBL29867829 | 0.91 | MME (0.47) | PDCD1LG2CD274BACE1CTSDMME | |
| SCHEMBL30799744 | 0.88 | BACE1 (0.45) | PDCD1LG2CD274BACE1CTSDMME | |
| SCHEMBL29630699 | 0.87 | ECE1 (0.51) | PDCD1LG2CD274BACE1CTSDECE1 | |
| SCHEMBL29630384 | 0.86 | PDCD1LG2 (0.53) | PDCD1LG2CD274BACE1CTSDMME | |
| SCHEMBL29384747 | 0.86 | PDCD1LG2 (0.61) | PDCD1LG2CD274BACE1CTSDMME | |
| SCHEMBL29382890 | 0.86 | PDCD1LG2 (0.61) | PDCD1LG2CD274BACE1CTSDMME | |
| SCHEMBL30063231 | 0.85 | ECE1 (0.47) | PDCD1LG2CD274BACE1CTSDMME | |
| SCHEMBL29386907 | 0.85 | MME (0.51) | PDCD1LG2CD274MME | |
| SCHEMBL29369310 | 0.85 | CD274 (0.52) | PDCD1LG2CD274BACE1CTSDMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388623-A1 | PEPTIDE INHIBITOR AND USE THEREOF | CHENGDU BRILLIANT INSPIRATION BIOTHERAPEUTICS CO LTD (CN) | 2025-12-25 | — | — | US | disclosed |
| WO-2022069704-A2 | IMMUNODIAGNOSTIC AGENTS AND METHODS FOR THE DETECTION AND DIFFERENTIATION OF CORONAVIRUS INFECTIONS | INSTITUT FÜR MOLEKULARE DIAGNOSTIK UND BIOANALYTIK (IMDB) GGMBH (DE) | 2022-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388623-A1 | PEPTIDE INHIBITOR AND USE THEREOF | VIP, TGFB1, FN1 | PDCD1LG2 2245/4885CD274 1635/4885BACE1 924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.